What the literature says a nurse does for a person with gout: assess the joint, give the medicines safely, teach, and keep urate on target. Every figure here is quoted from guidelines, drug labels and trials, not from local practice. Where the literature is silent, this module says so.
ScopeThis describes what guidelines, drug labels and published studies say. It is not a care plan, and it does not replace your service's protocols, your scope of practice or the prescriber. Doses are quoted as the labels and guidelines publish them, never as instructions.
1 · Assessing a flare
Schematic curves. No study publishes an hour-by-hour chart of a flare. The shape follows the published features (maximal pain within 24 hours, resolution within 14 days); the flare definition, the scales and the panel figures are cited.
Measuring it: tools with published validity
2 · Giving the medicines
Pegloticase: an infusion with a stopping rule
Schematic urate values. The schedule, the checks and the stopping rule are the US label's; the urate dots are illustrative, not a patient's results.
3 · The nurse-led treat-to-target loop
Bars show the published values at baseline, year 1 and year 2 of the Nottingham trial (517 people); between those points they are interpolated. The loop's pace is schematic, weighted to the first 6 months as the trial reports.
4 · What to teach, and what gets misunderstood
Staying on it
Points are the published values; the lines only join them.
5 · In hospital and after surgery
6 · What goes in the notes
Entry built from what you ticked
A worked example of the items the trial recorded. Your service decides the format.